Your Opportunity to engage with global life science partners
BioPharm America attracts a wide range of business leaders, including senior executives of leading biotech companies, business development teams from large and midsize pharmaceutical companies, investors and other industry experts.
Hear key biotech and pharma leaders discuss the latest industry trends in workshops and panels.
Attend five Xcelerate Keynote presentations by high-level industry experts in oncology, gene therapy, translational medicine and more.
Special offer for Startups!
Build new relationships, that will help you to get ahead. Engage with high-caliber strategic partners and investors to advance your startup company.
The Ultimate Biopharma Dealmakers Report for Alliances and M&As, Second Edition 2016–2019
Over the past 3 years, biopharma companies have inked more than 500 alliances where potential deal value of more than $50 million was disclosed. In this second edition, Chris Morrison expands on his analysis of game-changing deals with the addition of the most recent mega-deals as well as the aggregate effects of all alliances and acquisitions.
- Biopharma Alliance Trends
- Biopharma M&A Trends
- Top 10 Alliances by upfront deal value
- Top 16 M&A by upfront deal value